Dear Editor,
Bcl-2 family members play pivotal roles in regulation of apoptosis. They functionally and physically associate with the mitochondrial membrane and regulate mitochondria-mediated apoptotic signals either positively or negatively. The proapoptotic Bcl-2 subfamily can be divided into two groups. One possesses multiple domains, that is, three Bcl-2 homology domains 1–3 (BH1–3) and the other possesses a BH3 domain alone.1, 2 To date, at least eight BH3-only protein members (Bad, Bid, Bik/Blk, Bim/Bod, Bmf, Hrk, PUMA and Noxa) have been identified and all of them strongly induce apoptosis. Their proapoptotic activity is strictly controlled by transcriptional or post-translational regulation. For example, transcription of Noxa and Puma is activated in a p53-dependent manner, whereas Bad, Bim and Bmf are regulated by phosphorylation. Although Bim and Bmf directly bind to DLC (dynein light-chain) proteins, which are components of both dynein and myosin V motor complexes, they are sequestered from DLC proteins when they are phosphorylated.3, 4, 5 These unbound Bim and Bmf molecules are recruited to the mitochondrial membrane and interact with Bcl-2 or Bcl-XL, allowing inhibition of their antiapoptotic activity.6
There are a variety of Bim mRNA transcripts which are the products of alternative splicing.7 These various isoforms differ in size and may have different apoptotic activity. Some of them lack the BH3 domain and the others lack DLC-binding domain. These isoforms may function as decoys of proapoptotic Bim products, probably representing a novel regulatory mechanism for BH3-only proteins. Originally, three different Bim isoforms (BimEL, BimL and BimS) were found3 and thereafter a lot of other isoforms have been identified and the number is still expanding.8, 9 Indeed, reverse transcriptase-polymerase chain reaction (RT-PCR) technique and western blots clearly demonstrate that variable isoforms are abundantly expressed in a cell line (Figure 1a) and significant portions of Bim products other than BimEL, BimL and BimS isoforms were detected to exist variably in cell lines (Figure 1b), indicating that variable Bim transcripts are actually translated in cells. The biological functions of several novel Bim isoforms have already been characterized.8, 9, 10 These data imply roles of variable Bim isoforms in regulating the life and death of cells. Owing to the independent isolation by several laboratories, a wide variety of names have been used in the literature to refer to them. To facilitate the dissemination of information concerning these isoforms, we propose the name changes that are shown in Figure 2. These names describe the domain structure of the isoforms, that is, BimD has no BH3 domain, and thus this isoform is a kind of decoy. BimDd has a dynein-binding domain while BimED has exon 3, which is a feature of BimEL. Determination of the exon numbers was carried out on the basis of a matching process between cDNA and the genomic sequences according to the BAC clone RP11-438K19 (Accession number AC096670).
References
Adams JM and Cory S (1998) Science 281: 1322–1326
Adams JM and Cory S (2001) Trends Biochem. Sci. 26: 61–66
O'Connor L et al. (1998) EMBO J. 17: 384–395
Puthalakath H et al. (1999) Mol. Cell 3: 287–296
Yamaguchi H and Wang H-G (2002) J. Biol. Chem. 277: 41604–41612
Lei K and Davis RJ (2003) Proc. Natl. Acad. Sci. USA 100: 2432–2437
Bouillet P et al. (2001) Mamm. Genome 12: 163–168
Marani M et al. (2002) Mol. Cell. Biol. 22: 3577–3589
Mami U et al. (2001) FEBS Lett. 509: 135–141
Chen JZ et al. (2004) Int. J. Biochem. Cell Biol. 36: 1554–1561
Acknowledgements
This work was supported by Grants-in-Aid for Cancer Research and for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adachi, M., Zhao, X. & Imai, K. Nomenclature of dynein light chain-linked BH3-only protein Bim isoforms. Cell Death Differ 12, 192–193 (2005). https://doi.org/10.1038/sj.cdd.4401529
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401529
This article is cited by
-
BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review
Targeted Oncology (2018)
-
HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim
Scientific Reports (2017)
-
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
Nature Medicine (2012)
-
Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription
Cell Death & Disease (2011)
-
Bim: Guardian of Tissue Homeostasis and Critical Regulator of the Immune System, Tumorigenesis and Bone Biology
Archivum Immunologiae et Therapiae Experimentalis (2011)